Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Langdon

Showing results (91-100 of 180) with videos related to

Pageof 18
Sort By:
Endocrine-Related Cancer|December 3, 2005
Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogenAmanda J M O'Donnell, Kenneth G Macleod, David J Burns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroupAngela Bowman, Hani Gabra, Simon P Langdon, et al.
The Medical Journal of Australia|March 3, 1984
Intravenous cis-platinum for invasive bladder cancer. Safety and feasibility of a new approachD Raghavan, B Pearson, G Coorey, et al.
Plos One|December 19, 2015
Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel BiomarkersRomina Briffa, Inhwa Um, Dana Faratian, et al.
Gynecologic Oncology|July 13, 2007
Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancerGraeme Walker, Kenneth MacLeod, Alistair R W Williams, et al.
Biochemical Society Transactions|August 12, 2014
Novel flavonoids as anti-cancer agents: mechanisms of action and promise for their potential application in breast cancerCarlos Martinez-Perez, Carol Ward, Graeme Cook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancerH R Hendriks, H H Fiebig, R Giavazzi, et al.
British Journal of Cancer|April 1, 1995
c-erbB-3 protein expression in ovarian tumoursB J Simpson, J Weatherill, E P Miller, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2005
The mechanism of action of Kahalalide F: variable cell permeability in human hepatoma cell linesJ M Sewell, I Mayer, S P Langdon, et al.
Experimental and Molecular Pathology|July 3, 2024
FANCD2 expression affects platinum response and further characteristics of high grade serous ovarian cancer in cells with different genetic backgroundsSarah J Taylor, Robert L Hollis, Charlie Gourley, et al.
Pageof 18

Showing results (91-100 of 180) with videos related to

Sort By:
Pageof 18
Endocrine-Related Cancer|December 3, 2005
Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogenAmanda J M O'Donnell, Kenneth G Macleod, David J Burns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroupAngela Bowman, Hani Gabra, Simon P Langdon, et al.
The Medical Journal of Australia|March 3, 1984
Intravenous cis-platinum for invasive bladder cancer. Safety and feasibility of a new approachD Raghavan, B Pearson, G Coorey, et al.
Plos One|December 19, 2015
Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel BiomarkersRomina Briffa, Inhwa Um, Dana Faratian, et al.
Gynecologic Oncology|July 13, 2007
Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancerGraeme Walker, Kenneth MacLeod, Alistair R W Williams, et al.
Biochemical Society Transactions|August 12, 2014
Novel flavonoids as anti-cancer agents: mechanisms of action and promise for their potential application in breast cancerCarlos Martinez-Perez, Carol Ward, Graeme Cook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancerH R Hendriks, H H Fiebig, R Giavazzi, et al.
British Journal of Cancer|April 1, 1995
c-erbB-3 protein expression in ovarian tumoursB J Simpson, J Weatherill, E P Miller, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2005
The mechanism of action of Kahalalide F: variable cell permeability in human hepatoma cell linesJ M Sewell, I Mayer, S P Langdon, et al.
Experimental and Molecular Pathology|July 3, 2024
FANCD2 expression affects platinum response and further characteristics of high grade serous ovarian cancer in cells with different genetic backgroundsSarah J Taylor, Robert L Hollis, Charlie Gourley, et al.
Pageof 18